tiprankstipranks
Advertisement

TOUS - ETF AI Analysis

Compare

Top Page

TOUS

T. Rowe Price International Equity ETF (TOUS)

Rating:64Neutral
Price Target:
TOUS, the T. Rowe Price International Equity ETF, earns a solid overall rating driven by high-quality global leaders like ASML, AstraZeneca, and TotalEnergies, which bring strong financial performance, positive earnings outlooks, and generally attractive or fair valuations. Additional support comes from diversified holdings such as Siemens, UniCredit, Roche, and AXA, which add strength through profitability and strategic initiatives, though some names like Unilever and Roche face valuation or technical headwinds that slightly weigh on the fund. The main risk is that many top holdings show mixed or weak short-term momentum and, in some cases, rich valuations, which could increase volatility even though the underlying businesses are generally strong.
Positive Factors
Solid Recent Performance
The ETF has shown positive returns so far this year and over the past month, indicating recent upward momentum.
Global Diversification
Holdings spread across many countries, including Japan, the UK, the U.S., and several European and Asia-Pacific markets, help reduce reliance on any single economy.
Strong Leading Holdings
Several of the largest positions, such as ASML, Renesas Electronics, and TotalEnergies, have delivered strong gains, supporting the fund’s overall performance.
Negative Factors
Moderate Expense Ratio
The fund’s fee is not especially low, which can slightly reduce long-term returns compared with cheaper international ETFs.
Underperforming Key Stocks
Some notable holdings like UniCredit, Roche, and Unilever have been weak recently, which can drag on the ETF’s results if the trend continues.
Heavy Exposure to a Few Countries
A large share of assets is concentrated in Japan and the UK, increasing the impact that economic or market issues in those countries could have on the fund.

TOUS vs. SPDR S&P 500 ETF (SPY)

TOUS Summary

The T. Rowe Price International Equity ETF (TOUS) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to capture the total international market rather than tracking a single index. It holds a wide mix of companies across sectors and regions, including well-known names like ASML Holding and Unilever. Someone might consider this ETF to add global diversification to a U.S.-heavy portfolio and to benefit from growth in both developed and emerging markets. A key risk is that international stocks can be volatile and are affected by currency swings, politics, and global economic conditions.
How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.

TOUS Top 10 Holdings

TOUS leans heavily into developed markets outside the U.S., with Europe and Japan doing much of the heavy lifting. ASML and Renesas are the clear engines here, riding the global semiconductor and AI wave and giving the fund a strong tech undercurrent despite its broad mandate. Siemens and TotalEnergies add steady industrial and energy muscle, helping smooth out bumps. On the flip side, AstraZeneca and Unilever have been losing a bit of steam, acting as mild brakes rather than full-on drags, keeping overall performance more balanced than boom-or-bust.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.54%$50.87M€538.22B118.64%
76
Outperform
AstraZeneca2.38%$34.30M$290.06B33.35%
80
Outperform
Renesas Electronics1.87%$26.97M¥7.19T97.00%
64
Neutral
UniCredit SpA1.64%$23.66M€108.74B32.84%
75
Outperform
Rolls-Royce Holdings1.63%$23.40M£104.47B47.00%
71
Outperform
Siemens1.40%$20.18M€204.74B25.80%
74
Outperform
TotalEnergies SE1.39%$19.94M€175.13B47.09%
78
Outperform
Roche Holding AG1.32%$19.02M$339.86B35.69%
73
Outperform
1.26%$18.19M
Unilever1.21%$17.47M£92.54B-19.39%
72
Outperform

TOUS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
35.93
Positive
100DMA
36.15
Positive
200DMA
34.66
Positive
Market Momentum
MACD
0.32
Negative
RSI
58.65
Neutral
STOCH
92.63
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 36.75, equal to the 50-day MA of 35.93, and equal to the 200-day MA of 34.66, indicating a bullish trend. The MACD of 0.32 indicates Negative momentum. The RSI at 58.65 is Neutral, neither overbought nor oversold. The STOCH value of 92.63 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TOUS.

TOUS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.46B0.50%
64
Neutral
$5.91B0.27%
67
Neutral
$5.84B0.39%
58
Neutral
$2.20B0.54%
65
Neutral
$1.07B0.50%
63
Neutral
$1.07B0.24%
64
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TOUS
T. Rowe Price International Equity ETF
37.51
6.42
20.65%
DIHP
Dimensional International High Profitability ETF
DFIS
Dimensional International Small Cap ETF
CGIE
Capital Group International Equity ETF
SEIE
SEI Select International Equity ETF
DFSI
Dimensional International Sustainability Core 1 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement